SANOFI (1SAN.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1SAN - FR0000120578 - Common Stock
86.32 EUR
+0.01 (+0.01%)
Overall 1SAN gets a fundamental rating of 6 out of 10. We evaluated 1SAN against 55 industry peers in the Pharmaceuticals industry. While 1SAN has a great profitability rating, there are some minor concerns on its financial health. 1SAN has a decent growth rate and is not valued too expensively. 1SAN also has an excellent dividend rating. With these ratings, 1SAN could be worth investigating further for dividend investing!.
1. Profitability
1.1 Basic Checks
1SAN had positive earnings in the past year.
1SAN had a positive operating cash flow in the past year.
1SAN had positive earnings in each of the past 5 years.
In the past 5 years 1SAN always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of 1SAN (11.05%) is better than 76.36% of its industry peers.
With a decent Return On Equity value of 19.73%, 1SAN is doing good in the industry, outperforming 63.64% of the companies in the same industry.
1SAN has a Return On Invested Capital of 13.84%. This is in the better half of the industry: 1SAN outperforms 67.27% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1SAN is significantly below the industry average of 14.90%.
The 3 year average ROIC (7.31%) for 1SAN is below the current ROIC(13.84%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROIC | 13.84% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
1SAN has a Profit Margin of 20.35%. This is in the better half of the industry: 1SAN outperforms 78.18% of its industry peers.
1SAN's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 23.59%, 1SAN perfoms like the industry average, outperforming 56.36% of the companies in the same industry.
1SAN's Operating Margin has improved in the last couple of years.
1SAN has a Gross Margin (71.70%) which is comparable to the rest of the industry.
1SAN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1SAN is creating value.
1SAN has about the same amout of shares outstanding than it did 1 year ago.
1SAN has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, 1SAN has an improved debt to assets ratio.
2.2 Solvency
The Debt to FCF ratio of 1SAN is 2.21, which is a good value as it means it would take 1SAN, 2.21 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 2.21, 1SAN belongs to the best of the industry, outperforming 85.45% of the companies in the same industry.
1SAN has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of 1SAN (0.21) is better than 76.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Altman-Z | N/A |
ROIC/WACC1.81
WACC7.65%
2.3 Liquidity
A Current Ratio of 1.27 indicates that 1SAN should not have too much problems paying its short term obligations.
With a Current ratio value of 1.27, 1SAN perfoms like the industry average, outperforming 41.82% of the companies in the same industry.
A Quick Ratio of 0.94 indicates that 1SAN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.94, 1SAN is in line with its industry, outperforming 47.27% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 |
3. Growth
3.1 Past
The earnings per share for 1SAN have decreased by -5.35% in the last year.
1SAN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.10% yearly.
The Revenue has been growing slightly by 2.56% in the past year.
1SAN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.31% yearly.
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
3.2 Future
The Earnings Per Share is expected to grow by 7.06% on average over the next years.
The Revenue is expected to grow by 4.52% on average over the next years.
EPS Next Y3.07%
EPS Next 2Y5.75%
EPS Next 3Y6.01%
EPS Next 5Y7.06%
Revenue Next Year0.53%
Revenue Next 2Y3.48%
Revenue Next 3Y4.4%
Revenue Next 5Y4.52%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 11.36 indicates a reasonable valuation of 1SAN.
1SAN's Price/Earnings ratio is rather cheap when compared to the industry. 1SAN is cheaper than 83.64% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.15, 1SAN is valued rather cheaply.
The Price/Forward Earnings ratio is 10.05, which indicates a very decent valuation of 1SAN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1SAN indicates a somewhat cheap valuation: 1SAN is cheaper than 80.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.12, 1SAN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.36 | ||
| Fwd PE | 10.05 |
4.2 Price Multiples
61.82% of the companies in the same industry are more expensive than 1SAN, based on the Enterprise Value to EBITDA ratio.
1SAN's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.88 | ||
| EV/EBITDA | 11.08 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
1SAN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.7
PEG (5Y)2.23
EPS Next 2Y5.75%
EPS Next 3Y6.01%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.59%, 1SAN is a good candidate for dividend investing.
1SAN's Dividend Yield is rather good when compared to the industry average which is at 3.00. 1SAN pays more dividend than 87.27% of the companies in the same industry.
1SAN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.59% |
5.2 History
The dividend of 1SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
34.82% of the earnings are spent on dividend by 1SAN. This is a low number and sustainable payout ratio.
1SAN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.82%
EPS Next 2Y5.75%
EPS Next 3Y6.01%
BIT:1SAN (11/26/2025, 7:00:00 PM)
86.32
+0.01 (+0.01%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners47.5%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap210.27B
Revenue(TTM)66.91B
Net Income(TTM)13.81B
Analysts81.38
Price Target108.71 (25.94%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.59% |
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)9.77%
Revenue beat(16)9
Avg Revenue beat(16)21.47%
PT rev (1m)-0.46%
PT rev (3m)-1.25%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)-4.14%
EPS NY rev (1m)-1.01%
EPS NY rev (3m)-0.81%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)-1.69%
Revenue NY rev (1m)0.96%
Revenue NY rev (3m)0.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.36 | ||
| Fwd PE | 10.05 | ||
| P/S | 3.1 | ||
| P/FCF | 20.88 | ||
| P/OCF | 18.48 | ||
| P/B | 3 | ||
| P/tB | 22.62 | ||
| EV/EBITDA | 11.08 |
EPS(TTM)7.6
EY8.8%
EPS(NY)8.59
Fwd EY9.95%
FCF(TTM)4.13
FCFY4.79%
OCF(TTM)4.67
OCFY5.41%
SpS27.87
BVpS28.74
TBVpS3.82
PEG (NY)3.7
PEG (5Y)2.23
Graham Number70.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROCE | 16.7% | ||
| ROIC | 13.84% | ||
| ROICexc | 16.48% | ||
| ROICexgc | 66.95% | ||
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% | ||
| FCFM | 14.83% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexgc growth 3Y-13.63%
ROICexgc growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Debt/EBITDA | 0.75 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 58.05% | ||
| Profit Quality | 72.91% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | N/A |
F-Score7
WACC7.65%
ROIC/WACC1.81
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
EPS Next Y3.07%
EPS Next 2Y5.75%
EPS Next 3Y6.01%
EPS Next 5Y7.06%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
Revenue Next Year0.53%
Revenue Next 2Y3.48%
Revenue Next 3Y4.4%
Revenue Next 5Y4.52%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year30.73%
EBIT Next 3Y13.89%
EBIT Next 5Y11.66%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%
SANOFI / 1SAN.MI FAQ
Can you provide the ChartMill fundamental rating for SANOFI?
ChartMill assigns a fundamental rating of 6 / 10 to 1SAN.MI.
What is the valuation status for 1SAN stock?
ChartMill assigns a valuation rating of 6 / 10 to SANOFI (1SAN.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for SANOFI?
SANOFI (1SAN.MI) has a profitability rating of 7 / 10.
How financially healthy is SANOFI?
The financial health rating of SANOFI (1SAN.MI) is 5 / 10.
What is the earnings growth outlook for SANOFI?
The Earnings per Share (EPS) of SANOFI (1SAN.MI) is expected to grow by 3.07% in the next year.